When patients were divided into subgroups based on high or low DPD and TS expression , those with a DPD level below the median of 088 or a TS level of at least 200 had a significant prolongation of DFS after S-1 treatment compared with gemcitabine ( P = 0008 and P = 0035 respectively ) .